A University of Sydney team has proposed a depression subtype associated with disruption of the circadian system, the internal timing system that regulates sleep and waking. Published in the British Journal of Psychiatry, the study analysed 11,380 adults participating in the Australian Genetics of Depression Study. Of these, 2,604 — roughly a quarter — met the researchers' criteria for the proposed subtype.
Classification required at least three of six features: seasonal mood changes, delayed sleep timing, an evening preference, a mismatch between workday and free-day sleep schedules, excessive sleep, and fatigue upon waking. Depression began at approximately 19 in this group, compared with 23 among other participants. Those meeting the criteria also reported less benefit from common antidepressants and more adverse effects. Genetic analysis indicated greater inherited susceptibility to several conditions, including depression, anxiety, ADHD and bipolar disorder, as well as higher body weight and insomnia.
The researchers suggest that interventions targeting sleep–wake regulation, such as bright light therapy or melatonin, could prove useful. Nevertheless, the subtype remains a proposal, and clinical trials are necessary to establish treatment benefits. Independent sleep researcher Brant Hasler cautioned that self-reported sleep patterns do not necessarily demonstrate physiological circadian disruption. Psychiatrist Ruth Benca also noted that greater illness severity and other psychiatric conditions could contribute to poorer medication responses. The findings require validation in broader populations: participants came from a single Australian cohort, and the genetic analysis included only people of European ancestry.
